Pilot Study of Ginkgo biloba for Treatment of Vitiligo

Share

Szczurko O, Shear N, Taddio A, Boon H.
Ginkgo biloba for the treatment of vitiligo vulgaris: an open label pilot clinical trial.
BMC Complement Altern Med. 2011 Mar 15;11:21. doi: 10.1186/1472-6882-11-21.

Read free full text at PubMed Central.

Investigators at the University of Toronto and Hospital for Sick Children undertook a pilot clinical trial (n=12) to study the effect of Ginkgo biloba in patients 12 to 35 years old with vitiligo, a common depigmentation disorder “with significant psychological impact if occurring before adulthood.”

The authors review the epidemiology, pathogenesis, and current treatment of the disorder before describing their study, which found treatment with 60 mg of Ginkgo biloba twice daily was associated with improvement, based on validated outcome measures evaluating the area and intensity of depigmentation of vitiligo lesions. They recommend larger, randomized double-blind clinical trials.

Read free full text at PubMed Central.

The information on my blog is not intended as a substitute for medical professional help or advice but is to be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.